Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Orchard Therapeutics PLC Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$100 Billion
Q4 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$1.16 - $2.23 $64,526 - $124,045	-55,626 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$4.39 - $7.23 $117,388 - $193,330	-26,740 Reduced 32.46%	55,626 $244,000
Q1 2021 May 06, 2021	BUY	$4.39 - $9.08 $115,856 - $239,630	26,391 Added 47.15%	82,366 $598,000
Q4 2020 Feb 09, 2021	BUY	$3.86 - $5.07 $135,872 - $178,464	35,200 Added 169.43%	55,975 $242,000
Q3 2020 Nov 10, 2020	SELL	$4.11 - $6.45 $3,723 - $5,843	-906 Reduced 4.18%	20,775 $85,000
Q2 2020 Aug 06, 2020	BUY	$5.75 - $11.99 $26,938 - $56,173	4,685 Added 27.57%	21,681 $130,000
Q1 2020 May 11, 2020	BUY	$5.65 - $15.71 $18,904 - $52,565	3,346 Added 24.51%	16,996 $128,000
Q4 2019 Feb 05, 2020	BUY	$10.15 - $15.58 $138,547 - $212,667	13,650 New	13,650 $187,000

Others Institutions Holding ORTX

# of Institutions

Shares Held

545K

Call Options Held

Put Options Held

View Full List

About Orchard Therapeutics plc

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

More about ORTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account